Monday, May 2, 2016

In conversation with Paul Gunn

In conversation with Paul Gunn

April 26, 2016 by · Leave a Comment 

http://www.youtube.com/watch?v=Acau04X2Utk’]

Tweet As president and CEO of closely-held Soricimed Biopharma, Paul Gunn parlayed a 20-year career as a financial executive into funding the startup of Soricimed along with a tech transfer in 2005 facilitated by Mount Allison University in Sackville, New Brunswick, Canada. Admittedly, he was new to biotech and drug development in those days, but […]

Xagenic readies X1 molecular diagnostic beta trials

Xagenic readies X1 molecular diagnostic beta trials

April 19, 2016 by · Leave a Comment 

Tweet Closely-held Xagenic plans to conduct beta studies this year, in advance of a major chlamydia and gonorrhea clinical trial, with its rapid X1 molecular diagnostic testing system in preparation for market launches in Europe and the U.S. “The Xagenic X1 platform is a revolutionary diagnostic sys­tem that allows the user to perform lab-quality molecular […]

In conversation with Jerry Ropelato

In conversation with Jerry Ropelato

April 12, 2016 by · Leave a Comment 

http://www.youtube.com/watch?v=1Ak-sISGgn8′]

Tweet As CEO and founder of closely-held WhiteClouds, which operates the largest 3D color printing facility in the world, Jerry Ropelato is passionate about using the technology to create stunning models for the architecture, entertainment, retail and medical sectors. He points out that 3D printing is helping to further personalize healthcare and can play a […]

Microbix validating new virology production process

Microbix validating new virology production process

April 5, 2016 by · Leave a Comment 

Tweet Microbix Biosystems (TSX:MBX) is validating a new bioreactor manufacturing platform for its world-leading line of viral and bacterial antigens and other virology products ahead of a full roll-out to customers towards the end of 2016. “Once the new platform is fully implemented, it will reduce our manufacturing costs, greatly expand our available capacity and […]

Pivot Pharma seeks financing to develop drugs for women’s cancers

Pivot Pharma seeks financing to develop drugs for women’s cancers

March 29, 2016 by · Leave a Comment 

Tweet Upstart Pivot Pharmaceuticals (OTCQB:PVOTF), which was launched in the fourth quarter last year, is in talks with investors to raise up to $8-million in 2016 to initiate proof-of-concept studies for one of its two lead drug candidates for the treatment of endometrial and triple-negative breast cancers. “These women’s cancers represent areas of high unmet […]

Nobilis champions unique minimally-invasive ASC model

Nobilis champions unique minimally-invasive ASC model

March 22, 2016 by · Leave a Comment 

Tweet Nobilis Health (NYSE MKT:HLTH; TSX:NHC), which owns and operates ambulatory surgical centers (ASCs) and specialty surgical hospitals, has developed a unique patient acquisition strategy, bringing in patients via direct-to-consumer marketing to build surgeon practices rather than just managing facilities that surgeons use. “We have a very proactive, patient-acquisition model that is able to bring […]

Hamilton Thorne to accelerate acquisition program

Hamilton Thorne to accelerate acquisition program

March 15, 2016 by · Leave a Comment 

Tweet Hamilton Thorne (TSX-V:HTL), a leading provider of precision laser devices and advanced imaging systems, plans to accelerate its acquisition program, mainly in the human clinical in-vitro fertilization (IVF) market, as part of a long-term growth strategy that also includes product innovation and organic growth. “Our goal is to expand our product portfolio and capabilities […]

In conversation with David Luci

In conversation with David Luci

March 8, 2016 by · Leave a Comment 

Tweet As president, CEO and a co-founder of Dipexium Pharmaceuticals (NASDAQ:DPRX), David Luci, and executive chairman and co-founder, Robert DeLuccia, have spearheaded development of Locilex, which could be the first FDA-approved antibiotic specifically to treat mild infections of diabetic foot ulcers (DFI). The two men were instrumental in acquiring the worldwide writes to Locilex five […]

Revive readies key clinical studies in gout and kidney stones

Revive readies key clinical studies in gout and kidney stones

March 1, 2016 by · Leave a Comment 

Tweet Revive Therapeutics (TSX-V:RVV; OTCQB:RVVTF) hopes to begin a pivotal Phase 2b clinical trial in mid-year with its Bucillamine drug candidate for the treatment of acute gout flares. “We believe that the Phase 2b data in gout will be a partner-enabling study with a large pharmaceutical company,” CEO, Fabio Chianelli, says in an interview with […]

DME bringing personalized medicine to mental health

DME bringing personalized medicine to mental health

February 23, 2016 by · Leave a Comment 

Tweet Closely-held Digital Medical Experts (DME) is developing a low-cost personalized medicine technology that will assist physicians in diagnosing and selecting the most effective treatment for patients with mental health issues, including depression, schizophrenia and bipolar disorder. “We are using the mathematics of Big Data to move psychiatry out of an era where treatment decisions […]

Next Page »

Email Newsletters with Constant Contact
Google+